At Qubiotech we develop AI-assisted software for automatic and advanced neuroimaging analysis: Neurocloud, a CE marked tool for quantifying biomarkers in neurodegenerative diseases, which quickly, accurately and effectively helps the doctor (radiologist, neurologist and nuclear medicine doctor with PET, SPECT and MRI imaging) in the diagnosis and follow-up of the patient providing a complete report of the results in a few minutes. Neurocloud stands out for its experience of use and its clinically validated results (CE marked and FDA in progress) that help in the early diagnosis and monitoring of neurological diseases such as Multiple Sclerosis, Epilepsy, Parkinson's, Alzheimer's, etc. It has both cloud and on-premise versions with complete PACS integration no matter your structure. Neurocloud aims for total integration within your existing workflow. Neurocloud quantification allows you to go from subjective evaluations, which depend on the observer, to quantitative, reproducible evaluations, and therefore members of the same team can reach the same results with confidence while saving time in doing so. Qubiotech was born in the Neuroimaging Group of the University Hospital of Santiago de Compostela with the aim of bringing innovation in molecular image analysis to real clinical practice and also at a very low cost compared to the alternatives we had until now. Welcome to Augmented Neuroimaging. Welcome to Qubiotech.